Bluejay Diagnostics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Bluejay Diagnostics, Inc. (BJDX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $4240.00 per share for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2025-03-31
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2023-03-31 was $0.44, a 70.27% decline year-over-year.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2022-03-31 was $1.48.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $4240.00, a 14829.58% increase from fiscal 2022.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $28.40, a 2348.28% increase from fiscal 2021.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $1.16, a 78.46% increase from fiscal 2020.
- Bluejay Diagnostics, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $0.65.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2023-12-31 | $4240.00 10-K · filed 2025-03-31 | $10.60 10-K · filed 2024-03-28 | |||||
| 2023-09-30 | $70.40 10-Q · filed 2024-11-07 | $8.80 10-Q · filed 2023-11-09 | |||||
| 2023-06-30 | $70.40 10-Q · filed 2024-08-14 | $8.80 10-Q · filed 2023-08-14 | |||||
| 2023-03-31 | $0.44 10-Q · filed 2024-05-15 | ||||||
| 2022-12-31 | $28.40 10-K · filed 2024-03-28 | $1.42 10-K · filed 2023-03-20 | |||||
| 2022-09-30 | $29.00 10-Q · filed 2023-11-09 | $1.45 10-Q · filed 2022-11-09 | |||||
| 2022-06-30 | $28.33 10-Q · filed 2023-08-14 | $1.45 10-Q · filed 2022-08-10 | |||||
| 2022-03-31 | $1.48 10-Q · filed 2022-05-09 | ||||||
| 2021-12-31 | $1.16 10-K · filed 2023-03-20 | ||||||
| 2020-12-31 | $0.65 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |